nivolumab,rigosertib
onconova therapeutics,SymBio pharmaceuticals,Knight Therapeutics,bms
['rigoser', 'nivo', 'lung', 'nivolumab', 'onconova therapeutics', '$ontx']
$ontx onconova therapeutics therapeutics announces updated data from investigator-sponsored phase 1/2a trial evaluating rigosertib in combination with nivolumab in advanced kras-mutated non-small cell lung cancer at the esmo cong #cancer
Free Stock Market News are delayed 15 sec. Full features and live news available here: https://t.co/fWRacb3Vft